Gilead Licenses Long-Acting HIV Prevention Drug
Gilead signs deals with 6 generic drugmakers to sell HIV drug in low-income countries
Gilead Sciences said on Wednesday it has granted royalty-free licenses to six generic drug manufacturers to make and sell cheaper copycat versions of its HIV prevention medicine in 120 low and lower-middle income countries.
Gilead Partners With Generics Developers to Provide HIV Drug to Low-Income Countries
Gilead Sciences is granting licenses to six companies to produce lenacapavir for pre-exposure prophylaxis, as well as for treating human immunodeficiency virus in heavily pre-treated adults with multidrug-resistant infections.
Gilead Licenses Long-Acting HIV Prevention Drug to Generics Firms
Gilead Sciences Inc. said it is licensing its twice-yearly experimental HIV prevention drug lenacapavir to six generics makers after coming under fire from HIV advocates who argued the company was prioritizing profit over patients.
Gilead strikes voluntary licensing deals in poor countries for its pricey HIV drug
Gilead will license the HIV drug lenacapavir, a twice-yearly injectable, to six generic makers for 120 countries.
Biopharma firm Gilead announces lenacapavir licensing for HIV treatment
International AIDS Society, an association of HIV/AIDS professionals, applauded moves by Gilead Sciences, a biopharma company, to make the generic injectable lenacapavir for HIV prevention widely available, but cautioned that the current agreements still leave out millions around the world.
Gilead Licenses HIV-prevention Drug To Generic Drugmakers
US pharmaceutical giant Gilead said Wednesday it had signed licensing deals with six generic drugmakers to produce and sell its HIV prevention medicine in lower-income countries.
HIV prevention: why a new injectable drug could be such a breakthrough – podcast
HIV expert Linda-Gail Bekker talks to The Conversation Weekly about promising results from a trial of a new drug for HIV ...
‘Piss Bandit’ who taunts locals with urine bottles labeled ‘HIV positive’ is California’s number-one menace
The “Piss Bandit” has been leaving full bottles of urine on a street in Pasadena. Some see him as a menace, others a ...
Livesaving HIV drug will be sold cheap in Africa and Asia
US pharma company Gilead struck a deal with six companies, allowing them to make cheaper versions of the drug currently ...
US’s $100 Billion HIV Program Commits to African Manufacturing
The US President’s Emergency Plan for AIDS Relief, which represents the world’s biggest financial commitment to fight a ...
Why progress against HIV/AIDS has stalled among Hispanic and Latino Americans
Despite progress made against the HIV/AIDS crisis in the U.S, it has stalled for Hispanic and Latino Americans.
Aim to stop HIV transmission ‘in jeopardy’ after rise in cases
The aim of ending new cases of HIV in England is “at risk”, experts have warned after an increase in cases. New figures show ...
Queerty1d
Why has progress against HIV stalled among Hispanic & Latino Americans?
There was also a significant drop amongst Black men, of 18%, and across the southern states generally, of 16%. It’s ...
HIV cases soaring among Brits - and here's reason alarm being raised
Heterosexuals living outside of London have seen the largest increase in new HIV infection figures, according to new data ...